Maryam Sajjad, APRN
Psychiatric/Mental Health · Bellevue, WANPI 1144954959
Payments from drug & device makers
Across 41 payments — averaging $21.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$133
- Axsome Therapeutics, Inc.$112
- Neurocrine Biosciences, Inc.$99
- Lundbeck LLC$74
- AbbVie$62
- Tris Pharma Inc$55
- plus $329 from 10 others
What the payments were for
- Food & beverage$862100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 5 | $133 |
| Axsome Therapeutics, Inc. | 5 | $112 |
| Neurocrine Biosciences, Inc. | 3 | $99 |
| Lundbeck LLC | 4 | $74 |
| AbbVie | 3 | $62 |
| Tris Pharma Inc | 3 | $55 |
| Supernus Pharmaceuticals, Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| Noven Therapeutics, LLC | 2 | $42 |
| Validus Pharmaceuticals LLC | 2 | $40 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $37 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $35 |
| Insulet Corporation | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Novo Nordisk | 1 | $16 |
How this compares
$862 in reported general payments places this provider in the 70th percentile of 931 psychiatric/mental health providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buspirone Hcl | 24 | $642 |
| Bupropion XlBupropion Hcl | 14 | $482 |
| Hydroxyzine Hcl | 20 | $338 |
| Escitalopram Oxalate | 29 | $206 |
| Aripiprazole | 22 | $192 |
| Lamotrigine | 13 | $191 |
| Gabapentin | 16 | $181 |
| Risperidone | 13 | $146 |
| Clonazepam | 20 | $96 |
| Zolpidem Tartrate | 13 | $92 |
| Alprazolam | 25 | $84 |
| Trazodone Hcl | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Bellevue
- Angela CombsRichland$121K
- Ashley McGinnisAuburn$26K
- Courtney YantPuyallup$26K
- Dawn MasonSpokane$25K
- Janine TorresAuburn$24K
- Jennifer WilsonYakima$23K
- Patricia MorganKirkland$21K
- Kojo SarfoEllensburg$20K
- Brendan RoeVancouver$18K
- Jenna VoKent$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.